Patents by Inventor Mun-Ock KIM

Mun-Ock KIM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION CONTAINING ACANTHOPANAX EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF LIVER DISEASE
    Publication number: 20240261356
    Abstract: The present invention relates to a composition containing extracts from Garcinia cambogia and Acanthopanax for prevention or treatment of liver diseases and, more specifically, to a composition for prevention or treatment of liver disease, the composition containing, as active ingredients, (i) a Garcinia cambogia extract, hydroxycitric acid (HCA), or a derivative of hydroxycitric acid; and (ii) an Acanthopanax extract, Chiisanogenin, or a derivative of Chiisanogenin.
    Type: Application
    Filed: May 11, 2022
    Publication date: August 8, 2024
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Su Ui LEE, Mun-Ock KIM, Hyung Won RYU, Sei-Ryang OH, Doo-Young KIM, Jae-Won LEE
  • NOVEL COMPOUND ISOLATED FROM SPINACH, AND COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES
    Publication number: 20240254155
    Abstract: The present invention relates to a novel compound isolated from spinach, and a composition comprising same for preventing or treating inflammatory diseases, and, more particularly, to a novel medicagenic acid glycoside compound isolated from spinach, a preparation method therefor, and a composition comprising same for preventing or treating inflammatory diseases.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 1, 2024
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyung Won RYU, Su Ui LEE, Sei-Ryang OH, Jae-Won LEE, Doo-Young KIM, Hyun-Jae JANG, Mun-Ock KIM, Seong Hun JEONG
  • COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, COMPRISING ACANTHOPANAX SENTICOSUS EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM
    Publication number: 20230364170
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating obesity or diabetes, and to a food composition and feed composition for preventing or alleviating obesity or diabetes, comprising as an active ingredient, an Acanthopanax extract, a garcinia cambogia extract, or compounds isolated therefrom. The composition has synergistic antidiabetic and antiobesity activity compared to that of using only an Acanthopanax extract, a garcinia cambogia extract, or compounds isolated therefrom. Therefore, it is possible to reduce the possibility of any side effects that may be caused by an overdose of or long-term administration of the garcinia cambogia extract and a substance isolated therefrom, and thus the composition can be very effectively utilized in the development of a therapeutic agent for diabetes or obesity.
    Type: Application
    Filed: August 18, 2021
    Publication date: November 16, 2023
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Su Ui LEE, Hyung Won RYU, Mun Ock KIM, Sei Ryang OH, Doo Young KIM, Hyun Jae JANG
  • Indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient
    Patent number: 8906952
    Abstract: The present invention relates to an indole derivative, The indole derivative according to the present invention effectively inhibits the activity of diacylglycerol acyltransferase (DGAT) which induces metabolic diseases, such as obesity, diabetes, hyperlipidemia, or fatty liver and the like in lipid metabolism, thereby effectively regulating lipid metabolism and energy metabolism, and thus can be useful in pharmaceutical compositions for preventing or treating metabolic disease.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: December 9, 2014
    Assignee: Korea Research Institute of Bioscience & Biotechnology
    Inventors: Hyun Sun Lee, Mun-Ock Kim, Yongseok Choi, Kyeong Lee, Jeong-Jun Park, Jee-Hee Seo, Hwayoung Jung, Sungchan Cho
  • Novel Indole Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, and Pharmaceutical Composition for Preventing or Treating Metabolic Diseases Containing Same as Active Ingredient
    Publication number: 20140057909
    Abstract: The present invention relates to an indole derivative, The indole derivative according to the present invention effectively inhibits the activity of diacylglycerol acyltransferase (DGAT) which induces metabolic diseases, such as obesity, diabetes, hyperlipidemia, or fatty liver and the like in lipid metabolism, thereby effectively regulating lipid metabolism and energy metabolism, and thus can be useful in pharmaceutical compositions for preventing or treating metabolic disease.
    Type: Application
    Filed: November 4, 2013
    Publication date: February 27, 2014
    Applicant: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Hyun Sun LEE, Mun-Ock KIM, Yongseok CHOI, Kyeong Lee, Jeong-Jun PARK, Jee-Hee SEO, Hwayoung JUNG, Sungchan CHO